Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0410
0.00 (0.00%)
Mar 3, 2026, 9:30 AM EST
PLSH Revenue
Panacea Life Sciences Holdings had revenue of $1.06M in the quarter ending March 31, 2024, with 55.94% growth. This brings the company's revenue in the last twelve months to $2.76M, up 50.38% year-over-year. In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth.
Revenue (ttm)
2.76M
Revenue Growth
+50.38%
P/S Ratio
0.88
Revenue / Employee
69.10K
Employees
40
Market Cap
2.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.38M | 757.98K | 46.59% |
| Dec 31, 2022 | 1.63M | -432.65K | -21.01% |
| Dec 31, 2021 | 2.06M | -6.96M | -77.16% |
| Dec 31, 2020 | 9.02M | 6.82M | 310.19% |
| Dec 31, 2019 | 2.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eagle Pharmaceuticals | 257.55M |
| Medical Marijuana | 58.98M |
| Procyon | 4.98M |
| CannaPharmaRX | 1.71M |
| Bespoke Extracts | 1.42M |
| SOHM, Inc. | 1.30M |
| Redwood Scientific Technologies | 259.71K |
| Anything Technologies Media | 257.70K |